DL-AP5
Tocris Bioscience | Catalog # 0105
Key Product Details
Description
Alternative Names
Product Description
DL-AP5 is a racemic mixture of the D- and L-isomers of AP5, a selective NMDA receptor antagonist that competes with glutamate binding and is commonly used to inhibit NMDA-dependent synaptic plasticity. D-AP5 (Cat. No. 0106) is the more active isomer and displays approximately 52-fold higher potency than the L-isomer, L-AP5 (Cat. No. 0107). In vitro D-AP5 reduces NMDA-induced depolarization of cortical neurons, with no effect on the response to L-Quisqualic acid (Cat. No. 0188) or Kainic acid (Cat. No. 0222). Following spinal injection of D-AP5, NMDA-response is rapidly reduced, with no effect seen on spontaneously active neurons.
D-isomer, L-isomer and sodium salt also available.
Product Specifications for DL-AP5
Molecular Weight
Formula
Storage
Purity
Chemical Name
CAS Number
PubChem ID
InChI Key
SMILES
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
Solubility
| Solvent | Max Conc. mg/mL | Max Conc. mM | |
|---|---|---|---|
| Solubility | |||
| water | 1.97 | 10 | |
| 1eq. NaOH | 19.71 | 100 |
Preparing Stock Solutions for DL-AP5
The following data is based on the product molecular weight 197.13.
Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which all affect the solvent volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 1 mM | 5.07 mL | 25.36 mL | 50.73 mL |
| 5 mM | 1.01 mL | 5.07 mL | 10.15 mL |
| 10 mM | 0.51 mL | 2.54 mL | 5.07 mL |
| 50 mM | 0.10 mL | 0.51 mL | 1.01 mL |
Calculators
Background References
References are publications that support the biological activity of the product. See our Citations tab to view 344 publications citing the usage of this product.
- Evans The effect of a series of ω-phosphonic-α-carboxylic amino acids on electrically evoked and amino acid induced responses in isolated spinal cord preparations. Br.J.Pharmacol. 1982 PMID: 7042024
- Davies and Watkins Actions of D and L forms of 2-amino-5-phosphonovalerate and 2-amino-4-phosphonobutyrate in the cat spinal cord. Brain Res. 1982 PMID: 6145492
Product Documents for DL-AP5
Certificate of Analysis
To download a Certificate of Analysis, please enter a lot or batch number in the search box below.
Product Specific Notices for DL-AP5
For research use only
Related Research Areas
Citations for DL-AP5
Customer Reviews for DL-AP5 (4)
Have you used DL-AP5?
Submit a review and receive an Amazon gift card!
$25/€18/£15/$25CAN/¥2500 Yen for a review with an image
$10/€7/£6/$10CAN/¥1110 Yen for a review without an image
Submit a review
Customer Images
-
Species: MouseAssay Type: In VivoCell Line/Tissue: RetinaVerified Customer | Posted 07/25/2023Tested the effect of DL-AP5 on treatment-induced expression of the tested protein in retinal microvessels.
-
Species: MouseAssay Type: Ex VivoCell Line/Tissue: HypothalamusVerified Customer | Posted 06/21/2023Needs stirring to be diluted.AP5 was in use as a control pharmacological intervention to prove NMDAR-related nature of the registered whole-cell electrophysiological response. 20 microM/l AP5 supressed the response immediately. Red trace: whole-cell response without AP5; black trace: after AP5 application.
-
Species: MouseAssay Type: Ex VivoVerified Customer | Posted 10/02/2018Blocks NMDA currents as expected
-
Species: RatAssay Type: In VitroCell Line/Tissue: amygdala neuronsVerified Customer | Posted 01/04/20185 minutes perfusion at ~1.5ml/min was sufficient for the full effect.50uM used to antagonize NMDA receptors to isolate AMPA current.
There are no reviews that match your criteria.